Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway is a research paper published in International Immunopharmacology (2021). On theSindex it has a DataRank of 0.442. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Cancer Society
Grant: RSG-08-135-01-CNE
National Natural Science Foundation of China
Grant: 31172083
Priority Academic Program Development of Jiangsu Higher Education Institutions
Grant: PAPD-14KJB180010
National Institutes of Health
Grant: CA115414
NCI NIH HHS
Grant: R01 CA115414
National Institutes of Health
Grant: 5R01CA115414-03
mTOR Signaling in Tumor Cell Motility
FWCI
0.82
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals